Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Ppp2r1a haploinsufficiency increases excitatory synaptic transmission and decreases spatial learning by impairing endocannabinoid signaling
Yirong Wang, Weicheng Duan, Hua Li, Zhiwei Tang, Ruyi Cai, Shangxuan Cai, Guanghao Deng, Liangpei Chen, Hongyan Luo, Liping Chen, Yulong Li, Jian-Zhi Wang, Bo Xiong, Man Jiang
Yirong Wang, Weicheng Duan, Hua Li, Zhiwei Tang, Ruyi Cai, Shangxuan Cai, Guanghao Deng, Liangpei Chen, Hongyan Luo, Liping Chen, Yulong Li, Jian-Zhi Wang, Bo Xiong, Man Jiang
View: Text | PDF
Research Article Development Neuroscience

Ppp2r1a haploinsufficiency increases excitatory synaptic transmission and decreases spatial learning by impairing endocannabinoid signaling

  • Text
  • PDF
Abstract

Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase in the brain. Mutations in PPP2R1A, encoding the scaffolding subunit, are linked to intellectual disability, although the underlying mechanisms remain unclear. This study examined mice with heterozygous deletion of Ppp2r1a in forebrain excitatory neurons (NEX-het-conditional knockout [NEX-het-cKO]). These mice exhibited impaired spatial learning and memory, resembling Ppp2r1a-associated intellectual disability. Ppp2r1a haploinsufficiency also led to increased excitatory synaptic strength and reduced inhibitory synapse numbers on pyramidal neurons. The increased excitatory synaptic transmission was attributed to increased presynaptic release probability, likely due to reduced levels of 2-arachidonoyl glycerol (2-AG). This reduction in 2-AG was associated with increased transcription of monoacylglycerol lipase (MAGL), driven by destabilization of enhancer of zeste homolog 2 (EZH2) in NEX-het-cKO mice. Importantly, the MAGL inhibitor JZL184 effectively restored both synaptic and learning deficits. Our findings uncover an unexpected role of PPP2R1A in regulating endocannabinoid signaling, providing fresh molecular and synaptic insights into the mechanisms underlying intellectual disability.

Authors

Yirong Wang, Weicheng Duan, Hua Li, Zhiwei Tang, Ruyi Cai, Shangxuan Cai, Guanghao Deng, Liangpei Chen, Hongyan Luo, Liping Chen, Yulong Li, Jian-Zhi Wang, Bo Xiong, Man Jiang

×

Figure 2

Ppp2r1a haploinsufficiency increases excitatory synaptic transmission, decreases inhibitory synaptic transmission, and alters excitation-inhibition balance.

Options: View larger image (or click on image) Download as PowerPoint

Ppp2r1a haploinsufficiency increases excitatory synaptic transmission, ...
(A–C) Ppp2r1a haploinsufficiency increased mEPSC frequency (Control, n = 25 neurons; NEX-het-cKO, n = 20 neurons). (A) Representative mEPSC traces in mPFC L5 pyramidal neurons. (B) Cumulative distribution of interevent interval and summary of mEPSC frequency (inset). (C) Cumulative distribution and summary of mEPSC amplitude (inset). (D–F) Ppp2r1a haploinsufficiency increased AMPAR-mediated synaptic responses (Control, n = 20 neurons; NEX-het-cKO, n = 18 neurons). (D) Representative traces of evoked AMPAR-EPSCs. (E) Input/output plot of EPSC amplitude versus stimulation intensity. (F) Slope of input/output relationship. (G–I) Ppp2r1a haploinsufficiency increased NMDAR-mediated synaptic responses (Control, n = 22 neurons; NEX-het-cKO, n = 19 neurons). (G) Representative traces of evoked NMDAR-EPSCs. (H) Input/output plot of EPSC amplitude versus stimulation intensity. (I) Slope of input/output relationship. (J–L) Ppp2r1a haploinsufficiency decreased both the frequency and amplitude of mIPSCs (Control, n = 19 neurons; NEX-het-cKO, n = 15 neurons). (J) Representative mIPSC traces recorded in L5 pyramidal neurons. (K) Cumulative distribution of interevent interval and summary of mIPSC frequency (inset). (L) Cumulative distribution of mIPSC amplitude and summary graphs of mIPSC amplitude (inset). (M–P) Ppp2r1a haploinsufficiency increased E/I ratio (Control, n = 15 neurons; NEX-het-cKO, n = 16 neurons). (M) Representative traces of EPSCs and IPSCs. (N) Scatterplots depicting amplitudes of EPSCs and IPSCs recorded from both genotypes. (O) Increased E/I ratio in NEX-het-cKO mice. (P) Model illustrating that Ppp2r1a haploinsufficiency alters E/I balance. Statistical comparisons were performed using 2-tailed unpaired Student’s t test (C, K, and L), 2-tailed unpaired Student’s t test with Welch’s correction (I and O), 2-tailed Mann-Whitney test (B and F), 2-way ANOVA followed by Bonferroni’s post hoc test (E and H), and 2-tailed Kolmogorov-Smirnov test (cumulative distribution) (B, C, K, and L). All data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts